Q1 FY2026 EarningsQ3 FY25 revenue reached $1.81M, compared to zero revenue in the prior year, driven entirely by a new related-party medical supplies segment as electric vehicle sales stalled due to unfavorable market conditions. Net loss widened to $6.36M from $1.23M YoY, primarily due to $3.30M in non-cash intangible asset impairments and a $0.31M realized/unrealized loss on financial instruments. The company maintains a precarious liquidity position with just $77.6K in cash and negative working capital of $0.50M.